Navigate Fool.com
Will CELG beat
the market?

Celgene (NASDAQ: CELG)

Community Rating: 5 Stars: The Best

89.04 2.38 (2.75%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.50
Previous Close $86.66
Daily Range $87.80 - $89.16
52-Week Range $65.76 - $90.50
Market Cap $71.3B
P/E Ratio 55.20
Dividend (Yield) $0.00 (0.0%)
Volume 3,712,454
Average Daily Volume 4,884,136
Current FY EPS $3.18

How do you think CELG
will perform against the market?

Top CELG Bull/Bear Pitches


afketter (< 20)
Submitted May 8, 2014

Celgene has been brought down due to the whole biotech sector dropping, but they have solid earnings and are cheap on a 2016 basis. Not all of biotech will recover, but CELG will be one that moves a … More

0 Replies Reply Report this Post

NetscribeBiotech (< 20)
Submitted February 22, 2007

Celgene is a biopharmaceutical company focused on novel therapies to treat a broad range of hematopoietic, immunological, neuronal, and cancerous conditions. Celgene currently markets Thalomid for EN … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

Earnings Preview: Bristol-Myers Squibb and Celgene Corporation

Celgene and Bristol-Myers Squibb are set to report second quarter earnings this week. Here's what investors need to know.

Buy 100 Stocks Loved by Insiders

Insiders are snapping up shares of these companies, which include Celgene and Ubiquiti.

Biogen Shares Rebound As Street Has A Change Of Heart

Yellen Hates Biotech Stocks! Should You?

Are big biotechs -- Amgen, Biogen Idec, Gilead Sciences, and Celgene -- really overvalued, or is the Fed chairwoman looking at smaller companies?

Top Biotech Earnings Previews for the Week Ahead

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Fed: Beware of social media, biotech stocks

Are These the Best Big Biotech Stocks for Your Portfolio?

Watch below for more on this story.

Celgene Gets Bad News, Shares Climb Anyway

Celgene's Otezla failed a trial...and then shares jumped anyway.

Is Pharmacyclics the Next Celgene?

Pharmacyclics and Johnson & Johnson have a potential blockbuster in Imbruvica that may put Pharmacyclics on a similar path as Celgene.

See More CELG News...





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks